ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5575.1M
Enterprise Value 3432.24M
Trailing P/E 19.80
Forward P/E 131.87
PEG Ratio (5 yr expected) 13.08
Price/Sales (ttm)5.28
Price/Book (mrq)2.14
Enterprise Value/Revenue 33.96
Enterprise Value/EBITDA 610.48

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 27.44%
Operating Margin (ttm)32.42%

Management Effectiveness

Return on Assets (ttm)7.48%
Return on Equity (ttm)11.23%

Income Statement

Revenue (ttm)109.01M
Revenue Per Share (ttm)7.61
Quarterly Revenue Growth (yoy)16.30%
Gross Profit (ttm)74.28M
EBITDA 41.26M
Net Income Avi to Common (ttm)29.91M
Diluted EPS (ttm)2.04
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)166.74M
Total Cash Per Share (mrq)11.74
Total Debt (mrq)23.31M
Total Debt/Equity (mrq)8.66
Current Ratio (mrq)18.07
Book Value Per Share (mrq)18.93

Cash Flow Statement

Operating Cash Flow (ttm)33.79M
Levered Free Cash Flow (ttm)28.61M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.07
52-Week Change 3-12.14%
S&P500 52-Week Change 34.60%
52 Week High 346.43
52 Week Low 328.54
50-Day Moving Average 338.26
200-Day Moving Average 334.55

Share Statistics

Avg Vol (3 month) 3166.38k
Avg Vol (10 day) 3128.53k
Shares Outstanding 514.21M
Float 13.86M
% Held by Insiders 13.86%
% Held by Institutions 191.91%
Shares Short (May 31, 2019) 43.22M
Short Ratio (May 31, 2019) 414.5
Short % of Float (May 31, 2019) 430.81%
Short % of Shares Outstanding (May 31, 2019) 422.70%
Shares Short (prior month Apr 30, 2019) 42.63M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A